GlassScriptPhysician profile
Alejandro Santos Leal
NPI 1780847111
$6,545.78
in general payments reported to CMS, 2019-2025
38 companies · $1,468 in 2025
The $1,468 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $572 · 2021: $558 · 2022: $769 · 2023: $990 · 2024: $1,485 · 2025: $1,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,828 · Gift: $59.40 · Education: $55.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,828.38 |
| Gift | $59.40 |
| Education | $55.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,658.82 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $738.35 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $351.77 | 2019-2025 | Jardiance, Tradjenta |
| Mannkind Corporation | $290.99 | 2021-2025 | Afrezza |
| Amgen INC. | $285.29 | 2019-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $273.36 | 2021-2024 | |
| Beta Bionics, INC. | $252.06 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Xeris Pharmaceuticals, INC. | $239.57 | 2020-2025 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $226.29 | 2022-2025 | |
| Insulet Corporation | $206.86 | 2021-2025 | Omnipod |
| Amneal Pharmaceuticals LLC | $182.16 | 2019-2025 | Unithroid |
| Antares Pharma, INC. | $169.37 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Ibsa Pharma INC. | $163.82 | 2023-2025 | Tirosint, Licart, Flector |
| Merck Sharp & Dohme LLC | $151.87 | 2019-2023 | Steglatro |
| Abbvie INC. | $151.26 | 2021-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $129.76 | 2019-2024 | Korlym |
| Novartis Pharmaceuticals Corporation | $129.19 | 2023-2025 | |
| Recordati_rare_diseases_inc. | $115.72 | 2023-2025 | Signifor Lar, Isturisa |
| Tandem Diabetes Care, INC. | $107.56 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals LP | $96.31 | 2019-2022 | |
| Madrigal Pharmaceuticals | $83.92 | 2025 | Rezdiffra |
| Pfizer INC. | $78.18 | 2023-2025 | |
| Tolmar, INC. | $68.50 | 2024-2025 | Jatenzo |
| Dexcom, INC. | $59.86 | 2021-2024 | Dexcom G6 Transmitter |
| Sequel Med Tech, LLC | $47.94 | 2025 | Twiist |
| Amarin Pharma, INC. | $39.53 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $32.41 | 2019-2020 | |
| Radius Health, INC. | $28.38 | 2019 | |
| Abbott Laboratories | $28.22 | 2021-2025 | Freestyle Libre |
| Ascensia Diabetes Care US INC. | $24.90 | 2023 | |
| Medtronic, INC. | $20.82 | 2023 | Minimed 780g |
| Aimmune Therapeutics, INC. | $19.03 | 2025 | Zenpep |
| Zealand Pharma US, INC. | $16.93 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.51 | 2024 | Crysvita |
| Nestle Healthcare Nutrition INC. | $15.73 | 2020 | |
| Currax Pharmaceuticals LLC | $15.31 | 2024 | Contrave |
| Clarus Therapeutics INC. | $14.86 | 2021 | |
| Amphastar Pharmaceuticals, INC. | $14.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Santos Leal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.